• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Trending

Ticker Change

From 2025.10.31 (EST) changed to NCEL

Event Tracking

Oct30
NLS and Kadimastem Merge to Form NewCelX and Expand DOXA Platform
11:05
Oct29
NLS and Kadimastem Merge to Develop Type 1 Diabetes Cell Therapy Project
11:31
Oct7
NLS Pharmaceutics released FY2025 Q2 earnings on October 6 (EST), actual revenue USD 0, actual EPS USD -0.2674
03:00
NLS Pharmaceutics released FY2025 Semi-Annual Earnings on October 6 (EST), with actual revenue of USD 0 and EPS of USD -1.0469
03:00
NLS Pharmaceutics released FY2025 Q1 earnings on October 6, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.5234
03:00
Jul17
NLS Pharmaceutics Receives Milestone Funding Support from BIRD Foundation
13:01

Schedules & Filings

Schedules
Filings
Oct31
Ticker Change(EST)

From 10.31 changed to NCEL

Reverse Stock Split(EST)

1-for-10 Reverse Stock Split

Oct6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.096 M, EPS -0.5234

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MNDR
3.040
+83.13%
+1.380
SOND
0.1650
+79.15%
+0.073
EPSM
3.660
+66.36%
+1.460
VSA
0.2785
+59.05%
+0.103
PACS
26.140
+55.32%
+9.310
AIIO
0.7800
+41.77%
+0.230
LUD
9.620
+39.42%
+2.720
RDACR
0.2510
+32.11%
+0.061
PLAG
2.980
+31.28%
+0.710
IONZ
6.420
+28.40%
+1.420
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy